Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective
The recent lipid management guidelines emphasize using low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (non-HDL-C), and apo B levels as treatment targets. Out of these, LDL-C is the primary target of lipid management, non-HDL-C is the co-primary and ApoB is the seco...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jaypee Brothers Medical Publisher
2024-12-01
|
| Series: | Indian Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0244 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850185532248686592 |
|---|---|
| author | Shalini Gupta |
| author_facet | Shalini Gupta |
| author_sort | Shalini Gupta |
| collection | DOAJ |
| description | The recent lipid management guidelines emphasize using low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (non-HDL-C), and apo B levels as treatment targets. Out of these, LDL-C is the primary target of lipid management, non-HDL-C is the co-primary and ApoB is the secondary target. One-time estimation of lipoprotein(a) is sufficient presently to assess risk in view of the lack of specific drugs targeting it. Triglyceride levels ≥150 mg/dL in fasting and ≥175 mg/dL in non-fasting samples are considered risk modifiers for atherosclerotic cardiovascular disease. Lipid profile estimation in a non-fasting sample is considered good enough to manage a dyslipidemia patient. The inclusion of risk group-specific target range of lipid profile in biochemistry report format shall be more informative and helpful in ensuring better patient compliance. |
| format | Article |
| id | doaj-art-e0a0263be2cf45e1b83dc858e41f95ec |
| institution | OA Journals |
| issn | 0972-1207 2456-5164 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Jaypee Brothers Medical Publisher |
| record_format | Article |
| series | Indian Journal of Medical Biochemistry |
| spelling | doaj-art-e0a0263be2cf45e1b83dc858e41f95ec2025-08-20T02:16:40ZengJaypee Brothers Medical PublisherIndian Journal of Medical Biochemistry0972-12072456-51642024-12-01291454610.5005/jp-journals-10054-02447Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s PerspectiveShalini Gupta0https://orcid.org/0000-0002-5467-6255Shalini Gupta, Department of Biochemistry, Dr. B.R. Ambedkar State Institute of Medical Sciences, Sahibzada Ajit Singh Nagar, Mohali, Punjab, India, Phone: +91 9872667625The recent lipid management guidelines emphasize using low density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (non-HDL-C), and apo B levels as treatment targets. Out of these, LDL-C is the primary target of lipid management, non-HDL-C is the co-primary and ApoB is the secondary target. One-time estimation of lipoprotein(a) is sufficient presently to assess risk in view of the lack of specific drugs targeting it. Triglyceride levels ≥150 mg/dL in fasting and ≥175 mg/dL in non-fasting samples are considered risk modifiers for atherosclerotic cardiovascular disease. Lipid profile estimation in a non-fasting sample is considered good enough to manage a dyslipidemia patient. The inclusion of risk group-specific target range of lipid profile in biochemistry report format shall be more informative and helpful in ensuring better patient compliance.https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0244apolipoprotein bdyslipidemialow density lipoprotein cholesterolnon-high-density lipoprotein cholesterol |
| spellingShingle | Shalini Gupta Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective Indian Journal of Medical Biochemistry apolipoprotein b dyslipidemia low density lipoprotein cholesterol non-high-density lipoprotein cholesterol |
| title | Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective |
| title_full | Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective |
| title_fullStr | Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective |
| title_full_unstemmed | Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective |
| title_short | Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective |
| title_sort | latest indian guidelines for dyslipidemia management a biochemist s perspective |
| topic | apolipoprotein b dyslipidemia low density lipoprotein cholesterol non-high-density lipoprotein cholesterol |
| url | https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0244 |
| work_keys_str_mv | AT shalinigupta latestindianguidelinesfordyslipidemiamanagementabiochemistsperspective |